According to our cohort, HR-negative HER2-low breast cancers might represent a distinct molecular entity in Chinese patients with TNBC in terms of its special features in terms of molecular subtype, somatic mutations, gene expression and metabolic characteristics from HER2-0 tumors. The gene discussed is ERBB2; the disease is breast carcinoma.